Perrigo Banner

Product Search Results

103 products match your search.
Adapalene Cream, 0.1%
Generic to: Differin® Cream
Ammonium Lactate Cream, 12%
Generic to: Lac-Hydrin®
Ammonium Lactate Lotion, 12%
Compare to: Lac-Hydrin®
Bacitracin

Benzoyl Peroxide 10% Acne Medication Wash

Benzoyl Peroxide 10% Aqueous Base, Acne Treatment Gel

Benzoyl Peroxide 2.5% Aqueous Base, Acne Treatment Gel

Benzoyl Peroxide 5% Acne Medication Wash

Benzoyl Peroxide 5% Aqueous Base, Acne Treatment Gel

Betamethasone Dipropionate Cream, USP (Augmented), 0.05%
Generic to: Diprolene AF®
Betamethasone Dipropionate Lotion USP, 0.05%
Generic to: Diprosone®
Betamethasone Valerate Foam, 0.12%
Generic to: Luxiq®
Calcipotriene and Betamethasone Dipropionate Ointment, 0.005%/0.064%
Generic to: Taclonex®
Calcitriol Ointment, 3 mcg/g
Generic to: Vectical® Ointment
Ciclopirox Gel, 0.77%
Generic to: LOPROX®
Ciclopirox Olamine Cream USP, 0.77%
Generic to: Loprox®
Ciclopirox Olamine Topical Suspension USP, 0.77% (w/w) (Lotion)
Generic to: Loprox® Topical Suspension
Ciclopirox Shampoo, 1%
Generic to: Loprox®
Ciclopirox Topical Solution, 8%
Generic to: Penlac®
Clindamycin and Benzoyl Peroxide Topical Gel, 1%/5%
Generic to: Benzaclin®
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/5%
Generic to: DUAC® Gel
Clindamycin Phosphate Foam, 1%
Generic to: Evoclin®
Clindamycin Phosphate Topical Solution USP, 1%
Generic to: Cleocin-T®
Clindamycin Phosphate Topical Solution USP, 1% (Pledgets)
Generic to: Cleocin-T®
Clobetasol Propionate Foam (Emollient Formulation) 0.05%
Generic to: Olux-E®
Clobetasol Propionate Foam, 0.05%
Generic to: Olux®
Clobetasol Propionate Gel, 0.05%
Generic to: Temovate®
Clobetasol Propionate Lotion 0.05%

Clobetasol Propionate Shampoo, 0.05%
Generic to: Clobex® Shampoo
Clobetasol Propionate Topical Solution USP, 0.05% Spray
Generic to: Clobex® Spray
Clotrimazole Cream USP, 1%
Compare to the Active Ingredient of: Lotrimin® AF
Desonide Cream, 0.05%
Generic to: Tridesilon®
Desonide Ointment, 0.05%
Generic to: Tridesilon®
Desoximetasone Ointment USP, 0.25%
Generic to: Topicort®
Desoximetasone Cream USP, 0.25%
Generic to: Topicort®
Dibucaine Ointment 1%
Compare to the Active Ingredient of: Nupercainal®
Diphenhydramine HCl And Zinc Acetate Cream
Compare to the Active Ingredients of: Extra Strength Benadryl® Cream
Econazole Nitrate Cream, 1%
Generic to: Spectazole®
Ery 2% Pads
Generic to: Erycette®
Erythromycin Topical Gel USP, 2%
Generic to: Erygel®
Erythromycin Topical Solution USP, 2%

Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)
Generic to: Derma-Smoothe/FS®
Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil)
Generic to: Derma-Smoothe/FS®
Fluocinonide Cream USP, 0.1%
Generic to: Vanos®
Flurandrenolide Lotion USP, 0.05%
Generic to: Cordran®
Fluticasone Propionate Cream, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Lotion, 0.05%
Generic to: Cutivate®
Fluticasone Propionate Ointment, 0.005%
Generic to: Cutivate®
Gentamicin Sulfate Cream USP, 0.1%
Generic to: Garamycin®
Gentamicin Sulfate Ointment USP, 0.1%
Generic to: Garamycin®
Halobetasol Propionate Cream, 0.05%
Generic to: Ultravate®
Halobetasol Propionate Ointment, 0.05%
Generic to: Ultravate®
Hemorrhoidal Ointment
Compare to the Active Ingredients of: Preparation H® Ointment
Hydrocortisone 1% - Iodoquinol 1% Cream
Compare to the Active Ingredients of: Vytone®
Hydrocortisone 1% Ointment
Compare to the Active Ingredient of: Cortizone•10®
Hydrocortisone Acetate 1% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 1%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Analpram HC® Cream 2.5%
Hydrocortisone Acetate 2.5% Pramoxine HCl 1% Cream
Authorized Generic to: Pramosone® Cream 2.5%
Hydrocortisone Cream 1%
Compare to the Active Ingredient of: Cortaid®
Hydrocortisone Cream USP, 2.5%
Generic to: Hytone®
Hydrocortisone Lotion USP, 2.5%
Generic to: Hytone®
Hydrocortisone Ointment USP, 2.5%
Generic to: Hytone®
Hydrocortisone Valerate Cream USP, 0.2%
Generic to: Westcort®
Imiquimod Cream, 5%
Generic to: Aldara® Cream 5%
Isopropyl Alcohol 99%

Isopropyl Rubbing Alcohol 70% USP

Ketoconazole Foam, 2%
Generic to: Extina®
Ketoconazole Shampoo, 2%
Generic to: Nizoral®
Mometasone Furoate Cream USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Ointment USP, 0.1%
Generic to: Elocon®
Mometasone Furoate Topical Solution USP, 0.1%
Generic to: Elocon®
Mupirocin Ointment USP, 2%
Generic to: Bactroban®
Muscle Rub
Compare to the Active Ingredients of: Bengay®
Nystatin Cream USP, 100,000 U/G
Generic to: Mycostatin®
Nystatin Ointment USP, 100,000 U/G
Generic to: Mycostatin®
NYSTOP® Nystatin Topical Powder, USP
Compare to: MYCOSTATIN®
Permethrin Cream, 5%
Generic to: Elimite®
Podocon-25® (25% Podophyllin in benzoin tincture)

Podofilox Topical Solution 0.5%
Generic to: Condylox®
Scopolamine Transdermal System 1 mg/3 days
Generic to: TRANSDERM SCõP®
Selenium Sulfide Topical Suspension USP, 2.5% (Lotion)
Generic to: Selsun® Rx
Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Generic to: Klaron®
Tacrolimus Ointment 0.03%
Generic to: Protopic® Ointment 0.03%
Tacrolimus Ointment 0.1%
Generic to: Protopic® Ointment 0.1%
Testosterone Gel 12.5 mg of testosterone per pump actuation CIII
Generic to: Androgel® 1%
Testosterone Gel 25 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Testosterone Gel 50 mg of testosterone per packet CIII
Generic to: Androgel® 1%
Testosterone Topical Solution 30 mg/1.5 mL CIII
Generic to: Axiron®
Tretinoin Cream, USP 0.025%
Generic to: Retin-A®
Tretinoin Cream, USP 0.05%
Generic to: Retin-A®
Tretinoin Cream, USP 0.1%
Generic to: Retin-A®
Tretinoin Gel, USP 0.01%
Generic to: Retin-A®
Tretinoin Gel, USP 0.025%
Generic to: Retin-A®
Triamcinolone Acetonide Topical Aerosol USP, 0.147 mg/g
Generic to: Kenalog® Spray
Triamcinolone Acetonide Cream USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.1%
Generic to: Kenalog®
Triamcinolone Acetonide Cream USP, 0.5%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.025%
Generic to: Kenalog®
Triamcinolone Acetonide Ointment USP, 0.1%
Generic to: Aristocort®
Triamcinolone Acetonide Ointment USP, 0.5%
Generic to: Aristocort®
Triple Antibiotic Ointment
Compare to the Active Ingredients of: Neosporin®
Trolamine Salicylate 10%
Compare to the Active Ingredient of: Aspercreme®
Vitamin A and D Ointment
Compare to the Active Ingredients of: A+D® Original Ointment
Teature Clindamycin and Benzoyl Peroxide Topical Gel
Alogliptin
Generic DPP4i
Important Safety Information
  • Alogliptin is contraindicated in patients with a history of serious hypersensitivity reaction to alogliptin-containing products such as anaphylaxis, angioedema, or severe cutaneous adverse reactions.
  • Acute pancreatitis: There have been postmarketing reports of acute pancreatitis. If pancreatitis is suspected, promptly discontinue Alogliptin.
  • Hypersensitivity: There have been postmarketing reports of serious hypersensitivity reactions in patients treated with Alogliptin such as anaphylaxis, angioedema or severe cutaneous adverse reactions. In such cases, promptly discontinue Alogliptin, assess for other potential causes, institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes. Use caution in a patient with a history of angioedema with another DPP-4i because it is unknown whether such patients will be predisposed to angioedema.
  • Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal. Causality cannot be excluded. Baseline liver test panel is recommended. If liver injury is detected, promptly interrupt Alogliptin and assess patient for probable cause, then treat cause if possible, to resolution or stabilization. Do not restart Alogliptin if liver injury is confirmed and no alternative etiology can be found.
  • Hypoglycemia: Insulin and insulin secretagogues are known to cause hypoglycemia. A lower dose of the insulin or insulin secretagogue may be required to minimize the risk when used in combination with Alogliptin.
  • Arthralgia: Severe and disabling arthralgia has been reported in patients taking DPP-4 inhibitors. Consider as a possible cause for severe joint pain and discontinue drug if appropriate.
  • Macrovascular outcomes: There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction with Alogliptin or any other anti-diabetic drug.
  • Most common adverse reactions (4% of patients treated with Alogliptin 25 mg and more frequently than in patients who received placebo) were nasopharyngitis (4.4%), headache (4.2%), and upper respiratory tract infection (4.2%).

Patients taking Alogliptin should contact their health care professionals right away if they develop signs and symptoms of heart failure such as:

  • Unusual shortness of breath during daily activities
  • Trouble breathing when lying down
  • Tiredness, weakness, or fatigue
  • Weight gain with swelling in the ankles, feet, legs, or stomach Patients should not stop taking their medicine without first talking to their health care professionals.

Patients should not stop taking their medicine without first talking to their health care professionals.

Indication

Alogliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Alogliptin is not for treatment of type 1 diabetes or diabetic ketoacidosis.

Please see Full Prescribing Information, including Medication Guide for Alogliptin.

Perrigo
©2016 Perrigo Company, plc

check patient preferred tier status and lower generic co-pay options

Cookie Policy

By using our site you consent to the use of cookies in accordance with the terms of our privacy policy.

Hide this message
Perrigo on Facebook Perrigo on Twitter Perrigo on YouTube Perrigo on LinkedIn Perrigo RSS